Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesClinical/Medical PolicyColorado Rocky Mountain Medicaid Coverage | OpenPa…
    Ask Trek AI about this page
    ModifiedColorado Rocky Mountain Health PlansPolicy CS018OH.D

    Mandatory Medicaid Coverage of Routine Patient Costs in Qualifying Clinical Trials (for Ohio Only)

    Customize your policy alerts

    Sign up for Colorado Rocky Mountain Health Plans Policy CS018OH.D alerts

    Get alerted when Policy CS018OH.D changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs Medicaid coverage in Ohio for routine patient costs furnished to members participating in qualifying clinical trials. Coverage applies to otherwise covered routine services and trial-related complication care, subject to Ohio requirements and the policy’s qualification criteria and exclusions.

    Policy Summary
    PayerColorado Rocky Mountain Health Plans
    PolicyMandatory Medicaid Coverage of Routine Patient Costs in Qualifying Clinical Trials (for Ohio Only)
    Policy CodePolicy CS018OH.D
    Change TypeModified
    Effective DateNovember 1, 2026
    Next Review DateN/A
    Key ActionThe provider and principal investigator must attest to the appropriateness of the clinical trial and submit supporting medical-record documentation when requested.
    SourceLink
    POLICY UPDATE CHANGES

    Medical-record documentation requirements and limitations were added for coverage reviews.

    The references section was updated to reflect current information.

    Medical-record documentation requirements were added for coverage reviews.

    The references section was updated to reflect current supporting information.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Ohio onlyPolicy application
    1–4Qualifying trial phases
    3Qualification pathways
    3Routine cost examples
    3Cost exclusions

    Qualifying Clinical Trial Coverage

    Qualified Clinical Trial Criteria

    A clinical trial qualifies when the trial meets the definition of a qualified clinical trial and satisfies one of the following alternative qualification pathways.

    Qualified clinical trial

    • Qualifying pathway

      • Government or qualified research sponsorship: The study is approved, conducted, or supported by the National Institutes of Health, including the National Cancer Institute; Centers for Disease Control and Prevention; Agency for Healthcare Research and Quality; Centers for Medicare and Medicaid Services; a cooperative group or center of one of those entities; the Department of Defense; the Department of Veterans Affairs; or a qualified nongovernmental research entity identified in NIH center-support-grant guidelines.At least one listed entity

        Support may include in-kind contributions.

      • Peer-reviewed federal agency trial: The study is conducted under an Investigational New Drug exemption under section 505(i) of the Federal Food, Drug, and Cosmetic Act, or under an exemption for a biological product under section 351(a)(3) of the Public Health Service Act.IND or biological-product exemption

        The document separately identifies this as pathway 2.

      • Exempt drug trial: The study is a drug trial exempt from the requirement to have an exemption described in the preceding pathway.Exempt drug trial

        The document identifies this as pathway 3.

    Routine Patient Cost Coverage

    Routine patient costs are covered to the extent the items or services would otherwise be covered outside the clinical trial.

    Covered routine patient costs: The item or service is provided to the individual under the qualifying clinical trial, including care to prevent, diagnose, monitor, or treat complications resulting from trial participation; or it is required solely to provide or administer the investigational item or service.Otherwise covered outside the trial

    Examples include physician, laboratory, and medical imaging services.

    The investigational item or service that is the subject of the qualifying clinical trial is excluded when it is not otherwise covered outside the clinical trial.

    Items and services provided solely for clinical-trial data collection or analysis are excluded when they are not used in the member’s direct clinical management. This includes laboratory tests and imaging performed at a protocol-defined frequency that is inconsistent with the member’s signs, symptoms, or applicable standards of care.

    Items and services provided free of charge by the research sponsor to any person enrolled in the clinical trial are excluded from routine patient costs.

    Applicable Billing and Diagnosis Codes

    ModifierModifier
    Q0Investigational clinical service provided in a clinical research study that is in an approved clinical research study.
    Q1Routine clinical service provided in a clinical research study that is in an approved clinical research study.
    Covered When Criteria Are MetHCPCSCovered
    G0276Blinded procedure for lumbar stenosis, percutaneous image-guided lumbar decompression (PILD) or placebo-control, performed in an approved coverage with evidence development (CED) clinical trial.
    Clinical-trial procedures with noncovered or experimental componentsHCPCSNot Covered
    G0294Noncovered procedure(s) using either no anesthesia or local anesthesia only, in a Medicare qualifying clinical trial, per day.
    G2000Blinded administration of convulsive therapy procedure, either electroconvulsive therapy (ECT, current covered gold standard) or magnetic seizure therapy (MST, noncovered experimental therapy), performed in an approved IDE-based clinical trial, per treatment session.
    HCPCS CodeHCPCSCovered
    S9988Services provided as part of a Phase I clinical trial.
    S9990Services provided as part of a Phase II clinical trial.
    S9991Services provided as part of a Phase III clinical trial.
    S9992Transportation costs to and from trial location and local transportation costs (e.g., fares for taxicab or bus) for clinical trial participant and one caregiver/companion.
    S9994Lodging costs (e.g., hotel charges) for clinical trial participant and one caregiver/companion.
    S9996Meals for clinical trial participant and one caregiver/companion.
    Clinical Trial claim diagnosis codeICD-10
    Z00.6Encounter for examination for normal comparison and control in clinical research program.

    Documentation and Review Requirements

    Documentation Required

    Provider and Investigator Trial Attestation

    Coverage determinations are based on an attestation regarding the appropriateness of the qualifying Clinical Trial from the health care provider and principal investigator. The attestation must use the streamlined, uniform form developed for use by the Secretary and may reference publicly available trial information, such as ClinicalTrials.gov.

    Documentation Required

    Medical-Record Support for Medical Necessity

    The patient's medical record must contain documentation that fully supports the medical necessity of the requested services. Relevant documentation includes medical history, physical examination findings, and results of pertinent diagnostic tests or procedures.

    • Documentation supporting medical necessity should be legible.
    • Documentation must be maintained in the patient's medical record and made available upon request.

    Clinical Trial Context

    Clinical trials are prospective studies involving human volunteers that follow a research plan to evaluate medical products, procedures, or behavioral interventions. A trial may compare an investigational intervention with standard treatment, a placebo, no intervention, or another existing intervention to assess safety and effectiveness. This policy addresses coverage of routine care and management of complications that would otherwise be covered outside the trial, rather than an investigational service that is not otherwise covered.

    Clinical Trial Phases and Terms

    Qualified Clinical Trial
    DefinitionA clinical trial conducted in Phase 1, Phase 2, Phase 3, or Phase 4.
    ConditionThe trial must address the prevention, detection, or treatment of a serious or life-threatening disease or condition.
    Additional requirementThe trial must meet the requirements under Criteria for Qualified Clinical Trials.
    Early Phase 1
    TimingExploratory research conducted before traditional Phase 1 trials.
    Human exposureInvolves very limited human exposure to the drug.
    Purpose
    Policy Summary
    PayerColorado Rocky Mountain Health Plans
    PolicyMandatory Medicaid Coverage of Routine Patient Costs in Qualifying Clinical Trials (for Ohio Only)
    Policy CodePolicy CS018OH.D
    Change TypeModified
    Effective DateNovember 1, 2026
    Next Review DateN/A
    Key ActionThe provider and principal investigator must attest to the appropriateness of the clinical trial and submit supporting medical-record documentation when requested.
    SourceLink
    On This Page
    Qualifying Clinical Trial CoverageApplicable Billing and Diagnosis CodesDocumentation and Review RequirementsClinical Trial ContextClinical Trial Phases and Terms
    Documentation Required

    Medical Records Documentation

    Medical-record documentation may be required to assess whether the member meets the clinical criteria for coverage, but documentation does not guarantee coverage of the requested services. Maintain complete, legible records and provide them upon request.

    • Records must support the medical necessity of the requested services.
    • Include relevant history, examination, and pertinent diagnostic or procedure results.
    Denial Risk

    Excluded Trial Costs

    Routine patient costs do not include investigational items or services that are the subject of the qualifying Clinical Trial and are not otherwise covered outside the trial. Costs may also be excluded when services are provided solely for trial data collection or analysis, or when research sponsors provide the items or services free of charge.

    • Protocol-driven laboratory tests or imaging that are not consistent with the member's signs, symptoms, or standards of care may be excluded.
    • Items and services used in direct clinical management are distinguished from data-collection-only services.
    Billing Rule

    Ohio Medical-Necessity Review

    For Ohio requests, services identified as unproven or subject to a coverage or quantity limit are evaluated for medical necessity under Ohio Administrative Code 5160-101. For medical-necessity clinical coverage criteria, refer to Ohio Administrative Code Rule 5160-1-61, Non-Covered Services.

    Denial Risk

    Missing Attestation or Supporting Records

    Coverage review may require submission of the required provider and principal-investigator trial attestation and supporting medical-record documentation. Missing or insufficient materials may prevent assessment of whether the member meets the applicable clinical criteria; submission does not guarantee coverage.

    • Provide the streamlined, uniform trial-attestation form when requested.
    • Submit legible records supporting medical necessity, including relevant history, examination, and diagnostic or procedure results.
    Investigates how or whether a drug affects the body and has no therapeutic or diagnostic goals; examples include screening studies and microdose studies.
    Phase 1
    Primary focusResearch focused on the safety of a drug.
    ParticipantsUsually conducted with healthy volunteers and a small number of participants.
    Research goalsDetermines the drug’s most frequent and serious adverse events and often evaluates how the drug is broken down and excreted by the body.
    Phase 2
    Primary focusGathers preliminary data on whether a drug works in people with a certain condition or disease.
    ComparisonsParticipants may be compared with similar participants receiving a placebo or a different drug.
    Safety evaluationSafety continues to be evaluated, including short-term adverse events.
    Phase 3
    Primary focusGathers additional information about a drug’s safety and effectiveness.
    Study designStudies different populations and dosages and may evaluate the drug in combination with other drugs.
    ParticipantsThese studies typically involve more participants.
    Phase 4
    TimingResearch conducted after the U.S. Food and Drug Administration has approved a drug for marketing.
    Study requirementsIncludes post-market requirement and commitment studies required of, or agreed to by, the study sponsor.
    Research goalsGathers additional information about a drug’s safety, efficacy, or optimal use.